Answer
Aug 08, 2025 - 10:08 AM
Potential contraindications include a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and known hypersensitivity to cagrilintide, semaglutide, or any formulation components. Identifying these contraindications ensures safe and appropriate use of the medication.
